NCT06362369 2025-09-17A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy7 Hills Pharma, LLCPhase 1/2 Recruiting126 enrolled
NCT05426005 2025-03-19Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal CancerSun Yat-sen UniversityPhase 1/2 Recruiting28 enrolled
NCT04636008 2024-08-06Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal CancerWest China HospitalPhase 1/2 Recruiting20 enrolled